Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01926392 · ClinicalTrials.gov registry record · Phase 4
Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns
A Phase 4 study of Burn, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT01926392: Completed Phase 4 study of Burn, sponsored by University of Virginia.
NCT01926392 is a Phase 4 study of Burn that has completed, run by University of Virginia. The registered enrollment target is 8 participants, below the 52-participant average among 8 other Burn trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01926392, a Phase 4 study of Burn, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Partial thickness burns are a common, painful injury requiring a great deal of resources in their care. Silver sulfadizine is a commonly-used topical antimicrobial, but is difficult to remove due to its lipid base. We are comparing a water-based topical antimicrobial therapy to silver sulfadiazine and hypothesize that the water-based therapy is superior in terms of pain control and resources required to deliver care.
Primary Outcome
Pain is assessed on a 0-10 point scale using both the patient's reported value and correlating with the value derived from nursing assessment using the visual analog scale. This is recorded at defined time points before, during, and after the dressing change
Conditions Studied
Interventions
- DRUG water-soluble therapy
- DRUG silver sulfadiazine
Study Locations (1)
Virginia
- University of Virginia Health System - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-10 |
| Phase | Phase 4 |
What the finished NCT01926392 record still lists
NCT01926392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 52-participant average among 8 other Burn trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Burn appearing as the primary indexed condition, and to 2 interventions - of which water-soluble therapy is the first listed.
NCT01926392 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT01926392 about?
NCT01926392 is a clinical study titled "Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns". Partial thickness burns are a common, painful injury requiring a great deal of resources in their care. Silver sulfadizine is a commonly-used topical antimicrobial, but is difficult to remove due to its lipid base. We are comparing a water-based topical antimicrobial therapy to silver sulfadiazine a...
What is the current status of trial NCT01926392?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2011-04. Estimated completion is 2011-10.
What conditions does trial NCT01926392 study?
This clinical trial studies the following conditions: Burn.
What interventions are being tested in trial NCT01926392?
The interventions under investigation include: water-soluble therapy (DRUG), silver sulfadiazine (DRUG).
Who is sponsoring clinical trial NCT01926392?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01926392 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01926392's enrollment target sits among peer trials
8 9th of 8 the lowest of 8 other Burn trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Burn trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
COMPLETED · Phase 4
-
The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA
RECRUITING
-
Paraffin Wax and Exercise Prospective
RECRUITING · NA
-
Utilizing 3D Imaging for Burn Wound Assessment
RECRUITING
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia